Ever Source Wealth Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,270 shares of HALO stock, worth $122,489. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,270
Previous 2,381
4.66%
Holding current value
$122,489
Previous $124,000
4.03%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
536Shares Held
124MCall Options Held
177KPut Options Held
167K-
Black Rock Inc. New York, NY17.6MShares$951 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$696 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$358 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$219 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$184 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.52B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...